However, the genetic overexpression of FAK in DLBCL cell lines made these cells more resistant to E7123 treatment, as demonstrated by the higher viability of these cells compared with wild-type DLBCL cell lines (74). Here, PTK2 is linked to diffuse large B-cell lymphoma.